annual EBITDA:
$337.40M+$75.31M(+28.73%)Summary
- As of today (June 11, 2025), HAE annual EBITDA is $337.40 million, with the most recent change of +$75.31 million (+28.73%) on March 29, 2025.
- During the last 3 years, HAE annual EBITDA has risen by +$158.91 million (+89.02%).
- HAE annual EBITDA is now at all-time high.
Performance
HAE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$99.54M+$11.49M(+13.05%)Summary
- As of today (June 11, 2025), HAE quarterly EBITDA is $99.54 million, with the most recent change of +$11.49 million (+13.05%) on March 1, 2025.
- Over the past year, HAE quarterly EBITDA has increased by +$41.96 million (+72.87%).
- HAE quarterly EBITDA is now at all-time high.
Performance
HAE quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$337.40M+$41.96M(+14.20%)Summary
- As of today (June 11, 2025), HAE TTM EBITDA is $337.40 million, with the most recent change of +$41.96 million (+14.20%) on March 1, 2025.
- Over the past year, HAE TTM EBITDA has increased by +$75.31 million (+28.73%).
- HAE TTM EBITDA is now at all-time high.
Performance
HAE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
HAE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.7% | +72.9% | +28.7% |
| 3 y3 years | +89.0% | +126.2% | +89.0% |
| 5 y5 years | +57.9% | +81.7% | +57.9% |
HAE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +89.0% | at high | +87.1% | at high | +64.4% |
| 5 y | 5-year | at high | +93.9% | at high | >+9999.0% | at high | +149.5% |
| alltime | all time | at high | +814.4% | at high | +358.9% | at high | +870.4% |
HAE EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | $337.40M(+28.7%) | - | - |
| Mar 2025 | - | $99.54M(+13.0%) | $337.40M(+14.2%) |
| Dec 2024 | - | $88.05M(+8.8%) | $295.44M(+6.7%) |
| Sep 2024 | - | $80.91M(+17.5%) | $276.90M(+8.9%) |
| Jun 2024 | - | $68.89M(+19.6%) | $254.30M(-3.0%) |
| Mar 2024 | $262.10M(+5.1%) | - | - |
| Mar 2024 | - | $57.58M(-17.2%) | $262.10M(-0.6%) |
| Dec 2023 | - | $69.51M(+19.2%) | $263.63M(+1.0%) |
| Sep 2023 | - | $58.32M(-24.0%) | $260.96M(-4.3%) |
| Jun 2023 | - | $76.69M(+29.7%) | $272.82M(+9.4%) |
| Mar 2023 | $249.34M(+39.7%) | $59.11M(-11.6%) | $249.34M(+6.4%) |
| Dec 2022 | - | $66.85M(-4.7%) | $234.24M(+3.0%) |
| Sep 2022 | - | $70.17M(+31.9%) | $227.41M(+10.8%) |
| Jun 2022 | - | $53.21M(+20.9%) | $205.29M(+15.0%) |
| Mar 2022 | $178.50M(+2.6%) | $44.01M(-26.7%) | $178.50M(+32.0%) |
| Dec 2021 | - | $60.02M(+24.9%) | $135.22M(-0.9%) |
| Sep 2021 | - | $48.04M(+81.8%) | $136.40M(-18.8%) |
| Jun 2021 | - | $26.42M(+3495.0%) | $168.02M(-3.5%) |
| Mar 2021 | $174.03M(-18.5%) | $735.00K(-98.8%) | $174.03M(-23.7%) |
| Dec 2020 | - | $61.20M(-23.2%) | $228.07M(-2.9%) |
| Sep 2020 | - | $79.66M(+145.6%) | $234.83M(+1.2%) |
| Jun 2020 | - | $32.44M(-40.8%) | $231.94M(+8.6%) |
| Mar 2020 | $213.64M(+10.7%) | $54.77M(-19.4%) | $213.64M(+0.5%) |
| Dec 2019 | - | $67.96M(-11.5%) | $212.50M(+5.8%) |
| Sep 2019 | - | $76.77M(+443.1%) | $200.81M(+14.5%) |
| Jun 2019 | - | $14.13M(-73.6%) | $175.39M(-9.1%) |
| Mar 2019 | $192.96M(+25.8%) | $53.64M(-4.7%) | $192.96M(+9.3%) |
| Dec 2018 | - | $56.27M(+9.6%) | $176.58M(+23.0%) |
| Sep 2018 | - | $51.35M(+62.0%) | $143.61M(+3.5%) |
| Jun 2018 | - | $31.71M(-14.9%) | $138.71M(-9.6%) |
| Mar 2018 | $153.40M(+118.1%) | $37.26M(+59.9%) | $153.40M(+89.8%) |
| Dec 2017 | - | $23.29M(-49.9%) | $80.84M(-20.0%) |
| Sep 2017 | - | $46.45M(+0.1%) | $101.04M(-1.0%) |
| Jun 2017 | - | $46.40M(-231.4%) | $102.09M(+45.1%) |
| Mar 2017 | $70.35M(+53.0%) | -$35.30M(-181.2%) | $70.35M(-42.5%) |
| Dec 2016 | - | $43.49M(-8.4%) | $122.30M(+203.1%) |
| Sep 2016 | - | $47.50M(+224.0%) | $40.35M(+16.1%) |
| Jun 2016 | - | $14.66M(-11.9%) | $34.77M(-24.4%) |
| Mar 2016 | $45.97M(-64.4%) | $16.64M(-143.3%) | $45.97M(-29.9%) |
| Dec 2015 | - | -$38.45M(-191.7%) | $65.55M(-54.6%) |
| Sep 2015 | - | $41.92M(+62.1%) | $144.53M(+6.2%) |
| Jun 2015 | - | $25.86M(-28.6%) | $136.13M(+5.4%) |
| Mar 2015 | $129.12M(-0.6%) | $36.22M(-10.6%) | $129.12M(+0.0%) |
| Dec 2014 | - | $40.53M(+20.9%) | $129.08M(+1.5%) |
| Sep 2014 | - | $33.52M(+77.9%) | $127.22M(-7.2%) |
| Jun 2014 | - | $18.84M(-47.9%) | $137.03M(+5.5%) |
| Mar 2014 | $129.93M(+3.0%) | $36.18M(-6.4%) | $129.93M(-3.4%) |
| Dec 2013 | - | $38.67M(-10.8%) | $134.44M(+3.7%) |
| Sep 2013 | - | $43.33M(+268.8%) | $129.65M(+14.1%) |
| Jun 2013 | - | $11.75M(-71.1%) | $113.65M(-9.9%) |
| Mar 2013 | $126.17M(-8.0%) | $40.70M(+20.1%) | $126.16M(+5.9%) |
| Dec 2012 | - | $33.88M(+24.0%) | $119.14M(-3.3%) |
| Sep 2012 | - | $27.33M(+12.7%) | $123.22M(-3.0%) |
| Jun 2012 | - | $24.26M(-28.0%) | $127.09M(-8.4%) |
| Mar 2012 | $137.14M(-12.5%) | $33.67M(-11.3%) | $138.72M(-3.1%) |
| Dec 2011 | - | $37.96M(+21.7%) | $143.17M(-2.0%) |
| Sep 2011 | - | $31.20M(-13.1%) | $146.11M(-6.4%) |
| Jun 2011 | - | $35.90M(-5.8%) | $156.10M(-0.7%) |
| Mar 2011 | $156.80M(+25.2%) | $38.12M(-6.8%) | $157.14M(+16.9%) |
| Dec 2010 | - | $40.89M(-0.7%) | $134.38M(+3.2%) |
| Sep 2010 | - | $41.19M(+11.5%) | $130.19M(+3.3%) |
| Jun 2010 | - | $36.94M(+140.4%) | $125.97M(+0.6%) |
| Mar 2010 | $125.25M(+3.1%) | $15.36M(-58.1%) | $125.24M(-7.1%) |
| Dec 2009 | - | $36.71M(-0.7%) | $134.88M(+1.1%) |
| Sep 2009 | - | $36.97M(+2.1%) | $133.44M(+2.5%) |
| Jun 2009 | - | $36.21M(+44.9%) | $130.18M(+7.3%) |
| Mar 2009 | $121.53M(+19.8%) | $25.00M(-29.1%) | $121.29M(-3.3%) |
| Dec 2008 | - | $35.27M(+4.6%) | $125.39M(+6.8%) |
| Sep 2008 | - | $33.71M(+23.4%) | $117.43M(+10.9%) |
| Jun 2008 | - | $27.32M(-6.1%) | $105.85M(+4.3%) |
| Mar 2008 | $101.48M | $29.10M(+6.5%) | $101.49M(-2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | - | $27.31M(+23.5%) | $104.34M(+3.4%) |
| Sep 2007 | - | $22.12M(-3.6%) | $100.94M(+0.4%) |
| Jun 2007 | - | $22.96M(-28.1%) | $100.50M(+1.0%) |
| Mar 2007 | $99.32M(-20.0%) | $31.95M(+33.6%) | $99.47M(+1.5%) |
| Dec 2006 | - | $23.91M(+10.3%) | $98.03M(-19.4%) |
| Sep 2006 | - | $21.68M(-1.2%) | $121.63M(-0.5%) |
| Jun 2006 | - | $21.94M(-28.1%) | $122.28M(-1.5%) |
| Mar 2006 | $124.17M(+41.9%) | $30.50M(-35.8%) | $124.17M(+6.8%) |
| Dec 2005 | - | $47.51M(+112.7%) | $116.29M(+28.5%) |
| Sep 2005 | - | $22.33M(-6.3%) | $90.48M(+1.4%) |
| Jun 2005 | - | $23.83M(+5.3%) | $89.22M(+1.9%) |
| Mar 2005 | $87.52M(+13.0%) | $22.62M(+4.3%) | $87.52M(-0.5%) |
| Dec 2004 | - | $21.70M(+2.9%) | $87.96M(+0.0%) |
| Sep 2004 | - | $21.08M(-4.7%) | $87.95M(+4.7%) |
| Jun 2004 | - | $22.12M(-4.1%) | $84.02M(+8.2%) |
| Mar 2004 | $77.44M(+17.5%) | $23.06M(+6.4%) | $77.67M(+15.9%) |
| Dec 2003 | - | $21.68M(+26.4%) | $67.01M(+3.0%) |
| Sep 2003 | - | $17.15M(+8.8%) | $65.06M(+0.2%) |
| Jun 2003 | - | $15.77M(+27.2%) | $64.92M(-1.5%) |
| Mar 2003 | $65.91M(-8.5%) | $12.40M(-37.2%) | $65.91M(-18.7%) |
| Dec 2002 | - | $19.74M(+16.0%) | $81.06M(+19.4%) |
| Sep 2002 | - | $17.02M(+1.5%) | $67.86M(-7.6%) |
| Jun 2002 | - | $16.76M(-39.2%) | $73.45M(-17.8%) |
| Mar 2002 | $72.06M(-11.1%) | $27.55M(+320.9%) | $89.30M(-8.1%) |
| Dec 2001 | - | $6.54M(-71.0%) | $97.13M(-9.7%) |
| Sep 2001 | - | $22.60M(-30.7%) | $107.59M(+8.4%) |
| Jun 2001 | - | $32.61M(-7.8%) | $99.21M(+22.6%) |
| Mar 2001 | $81.02M(+10.8%) | $35.37M(+108.1%) | $80.92M(+11.7%) |
| Dec 2000 | - | $17.00M(+19.5%) | $72.47M(+3.9%) |
| Sep 2000 | - | $14.23M(-0.6%) | $69.77M(-2.6%) |
| Jun 2000 | - | $14.31M(-46.8%) | $71.64M(-2.2%) |
| Mar 2000 | $73.13M(-9.5%) | $26.93M(+88.3%) | $73.23M(-12.9%) |
| Dec 1999 | - | $14.30M(-11.2%) | $84.06M(-0.1%) |
| Sep 1999 | - | $16.10M(+1.3%) | $84.16M(-1.3%) |
| Jun 1999 | - | $15.90M(-57.9%) | $85.26M(+4.3%) |
| Mar 1999 | $80.76M(+49.8%) | $37.76M(+162.2%) | $81.76M(+59.1%) |
| Dec 1998 | - | $14.40M(-16.3%) | $51.40M(-0.4%) |
| Sep 1998 | - | $17.20M(+38.7%) | $51.60M(+4.2%) |
| Jun 1998 | - | $12.40M(+67.6%) | $49.50M(-4.8%) |
| Mar 1998 | $53.90M(-25.1%) | $7.40M(-49.3%) | $52.00M(-24.4%) |
| Dec 1997 | - | $14.60M(-3.3%) | $68.80M(+0.1%) |
| Sep 1997 | - | $15.10M(+1.3%) | $68.70M(-2.1%) |
| Jun 1997 | - | $14.90M(-38.4%) | $70.20M(-3.4%) |
| Mar 1997 | $72.00M(+6.8%) | $24.20M(+66.9%) | $72.70M(+16.9%) |
| Dec 1996 | - | $14.50M(-12.7%) | $62.20M(-5.5%) |
| Sep 1996 | - | $16.60M(-4.6%) | $65.80M(-1.9%) |
| Jun 1996 | - | $17.40M(+27.0%) | $67.10M(-0.4%) |
| Mar 1996 | $67.40M(+2.0%) | $13.70M(-24.3%) | $67.40M(-3.2%) |
| Dec 1995 | - | $18.10M(+1.1%) | $69.60M(+2.1%) |
| Sep 1995 | - | $17.90M(+1.1%) | $68.20M(+0.7%) |
| Jun 1995 | - | $17.70M(+11.3%) | $67.70M(+2.1%) |
| Mar 1995 | $66.10M(+5.8%) | $15.90M(-4.8%) | $66.30M(-0.5%) |
| Dec 1994 | - | $16.70M(-4.0%) | $66.60M(+0.3%) |
| Sep 1994 | - | $17.40M(+6.7%) | $66.40M(+2.0%) |
| Jun 1994 | - | $16.30M(+0.6%) | $65.10M(+4.0%) |
| Mar 1994 | $62.50M(+24.3%) | $16.20M(-1.8%) | $62.60M(+4.7%) |
| Dec 1993 | - | $16.50M(+2.5%) | $59.80M(+5.1%) |
| Sep 1993 | - | $16.10M(+16.7%) | $56.90M(+6.8%) |
| Jun 1993 | - | $13.80M(+3.0%) | $53.30M(+5.5%) |
| Mar 1993 | $50.30M(+36.3%) | $13.40M(-1.5%) | $50.50M(+6.1%) |
| Dec 1992 | - | $13.60M(+8.8%) | $47.60M(+9.2%) |
| Sep 1992 | - | $12.50M(+13.6%) | $43.60M(+9.0%) |
| Jun 1992 | - | $11.00M(+4.8%) | $40.00M(+8.7%) |
| Mar 1992 | $36.90M(-76.5%) | $10.50M(+9.4%) | $36.80M(-44.0%) |
| Dec 1991 | - | $9.60M(+7.9%) | $65.70M(-31.1%) |
| Sep 1991 | - | $8.90M(+14.1%) | $95.40M(-24.2%) |
| Jun 1991 | - | $7.80M(-80.2%) | $125.80M(-20.0%) |
| Mar 1991 | $157.30M | $39.40M(+0.3%) | $157.30M(+33.4%) |
| Dec 1990 | - | $39.30M(0.0%) | $117.90M(+50.0%) |
| Sep 1990 | - | $39.30M(0.0%) | $78.60M(+100.0%) |
| Jun 1990 | - | $39.30M | $39.30M |
FAQ
- What is Haemonetics annual EBITDA?
- What is the all time high annual EBITDA for Haemonetics?
- What is Haemonetics annual EBITDA year-on-year change?
- What is Haemonetics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Haemonetics?
- What is Haemonetics quarterly EBITDA year-on-year change?
- What is Haemonetics TTM EBITDA?
- What is the all time high TTM EBITDA for Haemonetics?
- What is Haemonetics TTM EBITDA year-on-year change?
What is Haemonetics annual EBITDA?
The current annual EBITDA of HAE is $337.40M
What is the all time high annual EBITDA for Haemonetics?
Haemonetics all-time high annual EBITDA is $337.40M
What is Haemonetics annual EBITDA year-on-year change?
Over the past year, HAE annual EBITDA has changed by +$75.31M (+28.73%)
What is Haemonetics quarterly EBITDA?
The current quarterly EBITDA of HAE is $99.54M
What is the all time high quarterly EBITDA for Haemonetics?
Haemonetics all-time high quarterly EBITDA is $99.54M
What is Haemonetics quarterly EBITDA year-on-year change?
Over the past year, HAE quarterly EBITDA has changed by +$41.96M (+72.87%)
What is Haemonetics TTM EBITDA?
The current TTM EBITDA of HAE is $337.40M
What is the all time high TTM EBITDA for Haemonetics?
Haemonetics all-time high TTM EBITDA is $337.40M
What is Haemonetics TTM EBITDA year-on-year change?
Over the past year, HAE TTM EBITDA has changed by +$75.31M (+28.73%)